{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:15:39Z","timestamp":1793196939155,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jacadv.2026.102596","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T07:11:34Z","timestamp":1771225894000},"page":"102596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension"],"prefix":"10.1016","volume":"5","author":[{"given":"Jorge","family":"Plutzky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam R.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Al Dhaybi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanita R.","family":"Aroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan N.","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Buse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Christofides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"DeFronzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo J.","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Handelsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-792X","authenticated-orcid":false,"given":"Luke","family":"Laffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-5096","authenticated-orcid":false,"given":"Florian","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance A.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia Cristina","family":"Tudor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Einhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jacadv.2026.102596_bib2","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"issue":"19","key":"10.1016\/j.jacadv.2026.102596_bib3","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102596_bib4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.amepre.2024.07.005","article-title":"Health care expenditures and use associated with hypertension among U.S. adults","volume":"67","author":"Wang","year":"2024","journal-title":"Am J Prev Med"},{"issue":"9","key":"10.1016\/j.jacadv.2026.102596_bib5","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.123.20894","article-title":"Characterization of individuals with apparent resistant hypertension using contemporary guidelines: insights from CV-QUIC","volume":"80","author":"Ebinger","year":"2023","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.jacadv.2026.102596_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41371-022-00749-y","article-title":"Resistant hypertension is associated with an increased cardiovascular risk compared to patients controlled on a similar multi-drug regimen","volume":"37","author":"Leiba","year":"2023","journal-title":"J Hum Hypertens"},{"issue":"16","key":"10.1016\/j.jacadv.2026.102596_bib7","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/eurheartj\/ehs368","article-title":"Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis","volume":"34","author":"Kumbhani","year":"2013","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacadv.2026.102596_bib8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000513782","article-title":"Cardiovascular and renal outcomes in patients with type-2 diabetes and chronic kidney disease identified in a United States administrative claims database: a population cohort study","volume":"145","author":"Folkerts","year":"2021","journal-title":"Nephron"},{"issue":"12","key":"10.1016\/j.jacadv.2026.102596_bib9","first-page":"1506","article-title":"Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database","volume":"26","author":"Folkerts","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"issue":"5","key":"10.1016\/j.jacadv.2026.102596_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11906-023-01282-0","article-title":"Resistant hypertension: disease burden and emerging treatment options","volume":"26","author":"Flack","year":"2024","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacadv.2026.102596_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fendo.2019.00321","article-title":"The pathophysiology and treatment of hypertension in patients with Cushing's syndrome","volume":"10","author":"Barbot","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.jacadv.2026.102596_bib12","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1210\/clinem\/dgac460","article-title":"Approach to the patient on antihypertensive therapy: screen for primary aldosteronism","volume":"107","author":"Mulatero","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jacadv.2026.102596_bib13","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jacadv.2026.102596_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/ijms23020673","article-title":"Pathophysiology of mild hypercortisolism: from the bench to the bedside","volume":"23","author":"Favero","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jacadv.2026.102596_bib15","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/dc24-2841","article-title":"Prevalence of hypercortisolism in difficult-to-control type 2 diabetes","volume":"48","author":"Buse","year":"2025","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jacadv.2026.102596_bib16","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.eprac.2021.07.014","article-title":"When to suspect hidden hypercortisolism in type 2 diabetes: a meta-analysis","volume":"27","author":"Aresta","year":"2021","journal-title":"Endocr Pract"},{"issue":"12","key":"10.1016\/j.jacadv.2026.102596_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.jacadv.2026.102596_bib18","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s40618-020-01484-2","article-title":"Hidden hypercortisolism: a too frequently neglected clinical condition","volume":"44","author":"Giovanelli","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.jacadv.2026.102596_bib19","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in Cushing's syndrome: a meta-analysis based on 5367 patients","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jacadv.2026.102596_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13114","article-title":"Clinical presentation and etiology of Cushing's syndrome: data from ERCUSYN","volume":"34","author":"Valassi","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"12","key":"10.1016\/j.jacadv.2026.102596_bib21","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2337\/dc25-1055","article-title":"Inadequately controlled type 2 diabetes and hypercortisolism: improved glycemia with mifepristone treatment","volume":"48","author":"DeFronzo","year":"2025","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jacadv.2026.102596_bib22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/HJH.0b013e3283521484","article-title":"Prevalence and associated factors of subclinical hypercortisolism in patients with resistant hypertension","volume":"30","author":"Martins","year":"2012","journal-title":"J Hypertens"},{"issue":"7","key":"10.1016\/j.jacadv.2026.102596_bib24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacadv.2026.102596_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fendo.2020.00347","article-title":"Glucocorticoid signaling and the aging heart","volume":"11","author":"Cruz-Topete","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.jacadv.2026.102596_bib26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.jacadv.2026.102596_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacadv.2026.102596_bib28","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fendo.2019.00766","article-title":"Toward a diagnostic score in Cushing's syndrome","volume":"10","author":"Braun","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102596_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/gs.2019.11.03","article-title":"Cardiovascular risk and mortality in patients with active and treated hypercortisolism","volume":"9","author":"Li","year":"2020","journal-title":"Gland Surg"},{"issue":"11","key":"10.1016\/j.jacadv.2026.102596_bib30","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/HJH.0000000000003252","article-title":"Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"40","author":"Fallo","year":"2022","journal-title":"J Hypertens"},{"issue":"9","key":"10.1016\/j.jacadv.2026.102596_bib31","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/HJH.0b013e32834937f3","article-title":"Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study","volume":"29","author":"Fallo","year":"2011","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.jacadv.2026.102596_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ecl.2018.02.005","article-title":"Mortality in patients with endogenous Cushing's syndrome","volume":"47","author":"Javanmard","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102596_bib33","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac045","article-title":"Increased mortality persists after treatment of Cushing\u2019s disease: a matched nationwide cohort study","volume":"6","author":"Bengtsson","year":"2022","journal-title":"J Endocr Soc"},{"issue":"12","key":"10.1016\/j.jacadv.2026.102596_bib34","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102596_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","article-title":"The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications","volume":"33","author":"Isidori","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacadv.2026.102596_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.861659","article-title":"The Na+\/H+ exchanger 3 in the intestines and the proximal tubule of the kidney: localization, physiological function, and key roles in angiotensin II-induced hypertension","volume":"13","author":"Nwia","year":"2022","journal-title":"Front Physiol"},{"issue":"8","key":"10.1016\/j.jacadv.2026.102596_bib37","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1113\/jphysiol.2013.267609","article-title":"Glucocorticoids and renal Na+ transport: implications for hypertension and salt sensitivity","volume":"592","author":"Hunter","year":"2014","journal-title":"J Physiol"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102596_bib38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11906-012-0297-0","article-title":"The ubiquitous mineralocorticoid receptor: clinical implications","volume":"14","author":"Hawkins","year":"2012","journal-title":"Curr Hypertens Rep"},{"issue":"38","key":"10.1016\/j.jacadv.2026.102596_bib39","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.jacadv.2026.102596_bib40","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an Endocrine Society Clinical Practice Guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jacadv.2026.102596_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1507\/endocrj.K10E-402","article-title":"Clinicopathological features of primary aldosteronism associated with subclinical Cushing's syndrome","volume":"58","author":"Hiraishi","year":"2011","journal-title":"Endocr J"},{"issue":"8","key":"10.1016\/j.jacadv.2026.102596_bib42","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s40618-024-02453-9","article-title":"Hypertension and Cushing's syndrome: hunt for the red flag","volume":"48","author":"Martino","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.jacadv.2026.102596_bib43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11102-023-01314-7","article-title":"Evaluating the burden of endogenous Cushing's syndrome using a web-based questionnaire and validated patient-reported outcome measures","volume":"26","author":"Page-Wilson","year":"2023","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.jacadv.2026.102596_bib44","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jc.2012-2893","article-title":"Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients","volume":"98","author":"Lambert","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacadv.2026.102596_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.662865","article-title":"Relacorilant, a selective glucocorticoid receptor modulator, induces clinical improvements in patients with Cushing syndrome: results from a prospective, open-label phase 2 study","volume":"12","author":"Pivonello","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jacadv.2026.102596_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1060884","article-title":"Individualized medical treatment options in Cushing disease","volume":"13","author":"Gilis-Januszewska","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.jacadv.2026.102596_bib47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ecl.2020.05.003","article-title":"Advances in the medical treatment of Cushing disease","volume":"49","author":"Tritos","year":"2020","journal-title":"Endocrinol Metab Clin North Am"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T02:54:05Z","timestamp":1786416845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2772963X26000128"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102596","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102596"}}